Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03511001 · ClinicalTrials.gov registry record · NA
Effects Among Smokers Who Use and Do Not Use E-Cigarettes
A NA study, sponsored by California State University, San Marcos.
- Completed
- Registry status
- NA
- Development phase
- 187
- Enrollment target
NCT03511001: Completed NA study, sponsored by California State University, San Marcos.
NCT03511001 is a NA study that has completed, run by California State University, San Marcos. The registered enrollment target is 187 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03511001, a NA study, has completed, sponsored by California State University, San Marcos.
- COMPLETED
- Registry status
- NA
- Development phase
- 187 participants
- Enrollment target
Study Summary
This study compares effects among Latino and African American cigarette smokers who use e-cigarettes with those who continue smoking as usual.
Primary Outcome
Urinary NNAL at week 6. Urinary NNAL measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS)
Interventions
- OTHER E-Cigarette Vs. Smoking as Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2018-05-17 |
| Est. Completion | 2019-09-26 |
| Phase | NA |
What the finished NCT03511001 record still lists
NCT03511001 is an interventional study that assigns participants to a tested intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which E-Cigarette Vs. Smoking as Usual is the first listed.
NCT03511001 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03511001 about?
NCT03511001 is a clinical study titled "Effects Among Smokers Who Use and Do Not Use E-Cigarettes". This study compares effects among Latino and African American cigarette smokers who use e-cigarettes with those who continue smoking as usual.
What is the current status of trial NCT03511001?
This trial is currently completed. It is a NA study. The enrollment target is 187 participants. The study started on 2018-05-17. Estimated completion is 2019-09-26.
What interventions are being tested in trial NCT03511001?
The interventions under investigation include: E-Cigarette Vs. Smoking as Usual (OTHER).
Who is sponsoring clinical trial NCT03511001?
This trial is sponsored by California State University, San Marcos, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03511001's enrollment target sits among peer trials
187 579th of 2000 higher than 1,422 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI